For more information, refer to the full study in Nature Communications.

The California Institute for Regenerative Medicine has awarded a $6 million grant to USC investigators pioneering a new first ...

Aimed at improving pancreatic cancer survival rate, the multi-center clinical trial employed comprehensive biomarker discovery to understand patient survival, enabling the development of new ...

which are particularly aggressive brain tumors. A 2010 case study marked the first time that research was published on the effects of treating a glioblastoma with a combination of standard therapy ...

When a child develops a brain tumor, early diagnosis is essential. Alan Cohen, M.D., director of pediatric neurosurgery at Johns Hopkins Children’s Center, shares the most common signs and symptoms ...

Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University and National Health Research Institutes, Taipei 110, Taiwan International Master Program in ...

The TP53 gene is a gene that is mutated in many cancers. It is the most common gene mutation found in cancer cells. A tumor-suppressor gene, TP53 codes for a protein that inhibits the development and ...

When it comes to brain tumors, as new treatment approaches are continually being explored through clinical trials, the standard of care for glioblastoma has remained largely consistent since 2005. It ...

3Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. *Corresponding Author: David A. Reardon, Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.

Why is this happening again? Sometimes I wonder... Like, a lot of families are affected by a brain tumor. But how many do you see are affected by two?" As Andy’s condition worsened, Jack took on the ...